183 related articles for article (PubMed ID: 19483424)
1. Retrospective analysis of management of patients presenting with acute urinary retention due to benign prostatic hyperplasia: a hospital based study.
Pandit RK; Agrawal CS; Chalise PR; Sapkota G
Kathmandu Univ Med J (KUMJ); 2008; 6(24):448-52. PubMed ID: 19483424
[TBL] [Abstract][Full Text] [Related]
2. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
Desgrandchamps F; De La Taille A; Doublet JD;
BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
[TBL] [Abstract][Full Text] [Related]
4. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
[TBL] [Abstract][Full Text] [Related]
5. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis.
Bansal A; Arora A
Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889
[TBL] [Abstract][Full Text] [Related]
6. The Reten-World survey of the management of acute urinary retention: preliminary results.
Emberton M; Fitzpatrick JM
BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
[TBL] [Abstract][Full Text] [Related]
7. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
Alan McNeill S
Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
[TBL] [Abstract][Full Text] [Related]
8. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
[TBL] [Abstract][Full Text] [Related]
9. Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey.
Manikandan R; Srirangam SJ; O'Reilly PH; Collins GN
BJU Int; 2004 Jan; 93(1):84-8. PubMed ID: 14678374
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of patients with a successful trial without catheter, after treatment with an alpha-adrenergic receptor blocker for acute urinary retention caused by benign prostatic hyperplasia.
Lo KL; Chan MC; Wong A; Hou SM; Ng CF
Int Urol Nephrol; 2010 Mar; 42(1):7-12. PubMed ID: 19449121
[TBL] [Abstract][Full Text] [Related]
11. Prostate size influences the outcome after presenting with acute urinary retention.
McNeill AS; Rizvi S; Byrne DJ
BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
[TBL] [Abstract][Full Text] [Related]
12. Saline bladder infusion vs standard catheter removal in patients with acute urinary retention related to benign prostatic hyperplasia: The BLAPERF Study.
Corral R; Boissier R; Depaquit TL; Gondran-Tellier B; Bastide C; Lechevallier E; Baboudjian M
Prog Urol; 2023 May; 33(6):319-324. PubMed ID: 36842924
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia.
Bhomi KK; Bhattachan CL
Nepal Med Coll J; 2011 Sep; 13(3):178-81. PubMed ID: 22808810
[TBL] [Abstract][Full Text] [Related]
14. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
McNeill SA; Hargreave TB; Roehrborn CG;
Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of conservatively managed acute urinary retention: prostate size matters.
Kumar V; Marr C; Bhuvangiri A; Irwin P
BJU Int; 2000 Nov; 86(7):816-9. PubMed ID: 11069406
[TBL] [Abstract][Full Text] [Related]
16. A prospective pilot study to validate the management protocol for patients presenting with acute urinary retention: a community-based, nonhospitalised protocol.
Gopi SS; Goodman CM; Robertson A; Byrne DJ
ScientificWorldJournal; 2006 Jun; 6():2436-41. PubMed ID: 17619714
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of in-and-out catheterization as a way of trial without catheterization strategy for treatment of acute urinary retention induced by benign prostate hyperplasia: variables predicting success outcome.
Ko YH; Kim JW; Kang SG; Jang HA; Kang SH; Park HS; Moon du G; Cheon J; Kim JJ; Lee JG
Neurourol Urodyn; 2012 Apr; 31(4):460-4. PubMed ID: 22331691
[TBL] [Abstract][Full Text] [Related]
18. Does acute urinary retention respond to alpha-blockers alone?
McNeill SA
Eur Urol; 2001 Mar; 39 Suppl 6():7-12. PubMed ID: 11306895
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound prostate parameters as predictors of successful trial without catheter after acute urinary retention in patients ongoing medical treatment for benign prostatic hyperplasia: a prospective multicenter study.
DE Nunzio C; Voglino O; Cicione A; Tema G; Cindolo L; Bada M; Lombardo R; Nacchia A; Trucchi A; Ships L; Gacci M; Milanesi M; Cito G; Serni S; Tubaro A
Minerva Urol Nephrol; 2021 Oct; 73(5):625-630. PubMed ID: 33200904
[TBL] [Abstract][Full Text] [Related]
20. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
Khan M; Khan AL; Khan S; Nawaz H
J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
